(Q34622281)

English

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

scientific article published on August 4, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

multicenter clinical trial

0 references

0 references

muscular atrophy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

29

object named as

Gen Sobue

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

8

object named as

Masashi Aoki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691641

18 June 2024

author name string

Masahisa Katsuno

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Haruhiko Banno

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Keisuke Suzuki

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yu Takeuchi

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Motoshi Kawashima

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ichiro Yabe

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hidenao Sasaki

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Mitsuya Morita

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Imaharu Nakano

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kazuaki Kanai

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Shoichi Ito

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kinya Ishikawa

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hidehiro Mizusawa

14

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tomotaka Yamamoto

15

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Shoji Tsuji

16

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kazuko Hasegawa

17

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Takayoshi Shimohata

18

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Masatoyo Nishizawa

19

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hiroaki Miyajima

20

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Fumio Kanda

21

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yasuhiro Watanabe

22

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kenji Nakashima

23

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Akira Tsujino

24

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Taro Yamashita

25

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Makoto Uchino

26

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yasushi Fujimoto

27

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Fumiaki Tanaka

28

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group

30

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20691641

18 June 2024

publication date

4 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Lancet Neurology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

875-884

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

X-linked bulbospinal neuronopathy: Kennedy disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

X-linked recessive bulbospinal neuronopathy. A clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Kennedy disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeat expansion disease: progress and puzzles in disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuronopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized open labelled comparative study of the efficacy, safety and tolerability of leuprorelin acetate 1M and 3M depot in patients with advanced prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Temporal and biomechanical characteristics of oropharyngeal swallow in younger and older men

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Videofluoroscopic assessment of patients with dysphagia: pharyngeal retention is a predictive factor for aspiration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between observations and measures of oral and pharyngeal residue from videofluorography and scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reliability testing of the quantitative myasthenia gravis score

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intra- and interrater variation in the evaluation of videofluorographic swallowing studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistics notes: Analysing controlled trials with baseline and follow up measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical features of spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects on bone mineral density and bone metabolism of 6 months' treatment with gonadotropin-releasing hormone analogues in Japanese women: comparison of buserelin acetate with leuprolide acetate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between manometric and videofluoroscopic measures of swallow function in healthy adults and patients treated for head and neck cancer with various modalities

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Alzheimer's disease: Moving towards a vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Side effects of androgen deprivation therapy: monitoring and minimizing toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970182-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(10)70182-4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34622281&oldid=2182671318"